TD Asset Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-164,472
| Closed | -$1M | – | 1238 |
|
|
2024
Q4 | $1M | Hold |
164,472
| – | – | ﹤0.01% | 1112 |
|
|
2024
Q3 | $2.8M | Hold |
164,472
| – | – | ﹤0.01% | 927 |
|
|
2024
Q2 | $1.13M | Buy |
164,472
+5,350
| +3% | +$36.8K | ﹤0.01% | 1143 |
|
|
2024
Q1 | $1.54M | Buy |
159,122
+75,670
| +91% | +$730K | ﹤0.01% | 1086 |
|
|
2023
Q4 | $693K | Hold |
83,452
| – | – | ﹤0.01% | 1251 |
|
|
2023
Q3 | $697K | Buy |
83,452
+41,726
| +100% | +$348K | ﹤0.01% | 1207 |
|
|
2023
Q2 | $385K | Buy |
41,726
+22,833
| +121% | +$211K | ﹤0.01% | 1303 |
|
|
2023
Q1 | $260K | Sell |
18,893
-13,666
| -42% | -$188K | ﹤0.01% | 1358 |
|
|
2022
Q4 | $554K | Hold |
32,559
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q3 | $633K | Hold |
32,559
| – | – | ﹤0.01% | 1253 |
|
|
2022
Q2 | $587K | Hold |
32,559
| – | – | ﹤0.01% | 1266 |
|
|
2022
Q1 | $870K | Sell |
32,559
-17,472
| -35% | -$467K | ﹤0.01% | 1255 |
|
|
2021
Q4 | $1.47M | Buy |
50,031
+8,745
| +21% | +$256K | ﹤0.01% | 1203 |
|
|
2021
Q3 | $2.72M | Buy |
41,286
+5,500
| +15% | +$362K | ﹤0.01% | 997 |
|
|
2021
Q2 | $2.43M | Sell |
35,786
-2,622
| -7% | -$178K | ﹤0.01% | 1034 |
|
|
2021
Q1 | $2.95M | Buy |
38,408
+8,207
| +27% | +$630K | ﹤0.01% | 986 |
|
|
2020
Q4 | $2.67M | Buy |
30,201
+9,527
| +46% | +$841K | ﹤0.01% | 950 |
|
|
2020
Q3 | $1.53M | Sell |
20,674
-4,200
| -17% | -$310K | ﹤0.01% | 972 |
|
|
2020
Q2 | $1.82M | Buy |
24,874
+1,300
| +6% | +$94.9K | ﹤0.01% | 901 |
|
|
2020
Q1 | $1.32M | Sell |
23,574
-5,200
| -18% | -$292K | ﹤0.01% | 928 |
|
|
2019
Q4 | $1.1M | Hold |
28,774
| – | – | ﹤0.01% | 1070 |
|
|
2019
Q3 | $511K | Buy |
+28,774
| New | +$511K | ﹤0.01% | 1167 |
|